The placement of Thomas Jurgensen, formerly of Ligand Pharmaceuticals, as Vice President/Intellectual Property Transfer. Jurgensen has extensive experience with corporate and securities Law, intellectual property, dispute resolution. He also has expertise in business strategy, forming corporations, fundraising, corporate partnering, business development and intellectual property in a wide variety of industries, including life sciences, consumer products, high-tech and professional services.
